Rybelsus vs. Victoza
See how Rybelsus and Victoza compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Rybelsus is a daily pill while Victoza is a daily injection, though both are GLP-1 receptor agonists approved for type 2 diabetes and cardiovascular risk reduction.
Both drugs carry a boxed warning for thyroid C-cell tumors and share nausea, diarrhea, and decreased appetite as common side effects.
Rybelsus is sometimes used off-label for weight loss in people without diabetes, while Victoza's higher-dose sibling Saxenda is FDA-approved for weight management.
Rybelsus vs. Victoza Drug Summary
Rybelsus
Rybelsus (semaglutide) is an oral GLP-1 receptor agonist used to control blood sugar in adults with type 2 diabetes and to lower cardiovascular risk in those with existing heart disease. It's taken as a tablet once a day on an empty stomach, starting at a low dose and increasing over about two months to a maintenance dose.
Victoza
Victoza (liraglutide) is an injectable GLP-1 receptor agonist used to manage blood sugar in adults and children 10 and older with type 2 diabetes, and to reduce cardiovascular risk in those with heart disease. It's given as a once-daily injection under the skin, with the dose increased weekly over about three weeks.
Rybelsus vs. Victoza Side Effects
Rybelsus
Victoza
Rybelsus vs. Victoza Dosage
Rybelsus
Victoza
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 1.8 mg once daily | Week 3 onward |
| Dose changes | 2 increases | Every week |
Rybelsus
| STAGE | DOSE | WHEN |
| Starting dose | 3 mg once daily | Days 1-30 |
| Maximum dose | 14 mg once daily | Day 61 onward |
| Dose changes | 2 increases | Every 30 days |
Victoza
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 1.8 mg once daily | Week 3 onward |
| Dose changes | 2 increases | Every week |
Rybelsus vs. Victoza Indications
Rybelsus
Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to lower the risk of major cardiovascular events in those who already have heart disease. It's also used off-label, though not FDA-approved, for weight loss in people without diabetes.
Blood sugar control in type 2 diabetes
Cardiovascular risk reduction with heart disease
Off-label: weight loss without diabetes
Victoza
Victoza is FDA-approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes, and to lower the risk of major cardiovascular events in those with existing heart disease. Its higher-dose version, Saxenda, is separately approved for chronic weight management.
Blood sugar control in type 2 diabetes
Cardiovascular risk reduction with heart disease
Approved for children 10 and older
Rybelsus vs. Victoza Pros and Cons
Rybelsus
Rybelsus offers the only oral option among GLP-1 receptor agonists, which can appeal to people who want to avoid needles. Because it's a pill, it requires strict dosing rules around food and water intake that injectable options don't need.
Pros
Only GLP-1 receptor agonist available as a pill
No injection or needle handling required
FDA-approved for cardiovascular risk reduction
Simple three-step titration schedule
Cons
Must be taken on an empty stomach with water
Requires waiting 30 minutes before eating or meds
Not approved for children
Not approved for chronic weight management
Victoza
Victoza has over a decade of real-world use and is approved for children as young as 10 with type 2 diabetes, unlike Rybelsus. Being an injection, it avoids the food and timing restrictions that come with an oral GLP-1 tablet.
Pros
Approved for children 10 and older with diabetes
No food or water timing restrictions
Long track record since 2010 approval
Higher-dose version (Saxenda) approved for weight loss
Cons
Requires daily self-injection
Needle disposal and site rotation needed
Needs refrigerated storage until first use
No oral option available
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.